KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Profit After Tax (2016 - 2026)

Alnylam Pharmaceuticals filings provide 18 years of Profit After Tax readings, the most recent being $206.0 million for Q1 2026.

  • On a quarterly basis, Profit After Tax rose 1228.66% to $206.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $502.3 million, a 317.96% increase, with the full-year FY2025 number at $313.7 million, up 212.79% from a year prior.
  • Profit After Tax hit $206.0 million in Q1 2026 for Alnylam Pharmaceuticals, up from $111.5 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $251.1 million in Q3 2025 to a low of -$405.9 million in Q3 2022.
  • Median Profit After Tax over the past 5 years was -$83.8 million (2024), compared with a mean of -$80.3 million.
  • Biggest five-year swings in Profit After Tax: tumbled 292.43% in 2025 and later surged 1228.66% in 2026.
  • Alnylam Pharmaceuticals' Profit After Tax stood at -$207.5 million in 2022, then surged by 33.55% to -$137.9 million in 2023, then surged by 39.24% to -$83.8 million in 2024, then soared by 233.17% to $111.5 million in 2025, then soared by 84.67% to $206.0 million in 2026.
  • The last three reported values for Profit After Tax were $206.0 million (Q1 2026), $111.5 million (Q4 2025), and $251.1 million (Q3 2025) per Business Quant data.